SEC Contract Filing

Filing Date: 2018-09-27

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex_124632.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
<head>
	<title>ex_124632.htm</title>
	<!-- Created by RDG HTML Converter v1.1.0.0 9/26/2018 9:45:13 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-left: 10px; margin-right: 10px;">
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 36pt; text-align: right;"><b>Exhibit 10.2</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">AGREEMENT (this &ldquo;Agreement&rdquo;), dated as of September 21, 2018, by and between Brain Scientific Inc., a Nevada corporation (formerly known as All Soft Gels Inc.; the &ldquo;Company&rdquo;) and Amer Samad (the &ldquo;Controlling Shareholder&rdquo;).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">RECITALS</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">WHEREAS, the Controlling Shareholder is as of the date hereof the record and beneficial owner of 6,000,000 shares (the &ldquo;6M Shares&rdquo;) of the common stock, par value $0.001 per share, of the Company (&ldquo;Common Stock&rdquo;); and</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">WHEREAS, the Controlling Shareholder, as part of a series of prior transactions, was supposed to have received through the transfer of issued and outstanding shares of Common Stock, an additional 495,000 shares of Common Stock (the &ldquo;Additional Shares&rdquo;), for a total aggregate number of shares of Common Stock, including the 6M Shares, of 6,495,000 to be beneficially and of record owned by the Controlling Shareholder (collectively, the &ldquo;Control Shares&rdquo;); and</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">WHEREAS, the Additional Shares have not yet been transferred to the Controlling Shareholder; and</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">WHEREAS, the Company, on the date hereof, entered into a merger agreement (the &ldquo;Merger Agreement&rdquo;) with Memory MD, Inc., a Delaware corporation (&ldquo;MemoryMD&rdquo;), and AFGG Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company, to acquire Memory MD, pursuant to which, among other things, (a) MemoryMD became a wholly-owned subsidiary of the Company and (b) as a closing condition, the Controlling Shareholder agreed to transfer back to the Company and to have cancelled the Control Shares; and</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">WHEREAS, the transactions contemplated by the Merger Agreement are being consummated on the date hereof (the &ldquo;Closing&rdquo;); however, the Control Shares were not transferred back to the Company or cancelled as of the Closing; and</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">WHEREAS, the Company and the Controlling Shareholder wish to enter into this Agreement to provide for the terms and conditions of the Controlling Shareholder tendering for cancellation all of the Control Shares post-Closing.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">NOW, THEREFORE, in consideration of the foregoing and the representations, warranties and covenants herein contained, and for other good and valuable consideration, the receipt, adequacy and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Controlling Shareholder agrees to and shall use his best efforts to cause the prompt transfer to the Company of the 6M Shares, for cancellation.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">2.&nbsp;&nbsp;&nbsp